Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
8.28
-0.28 (-3.27%)
Apr 3, 2025, 1:55 PM EDT - Market open
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $704.33 million as of April 3, 2025. Its market cap has increased by 77.95% in one year.
Market Cap
704.33M
Enterprise Value
607.37M
1-Year Change
77.95%
Ranking
Category
Stock Price
$8.28
Market Cap Chart
Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $704.33M, an increase of 1,083.75%. That is a compound annual growth rate of 14.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 728.10M | -20.07% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | 1,752.88% |
| Dec 31, 2014 | 10.40M | 11.83% |
| Dec 31, 2013 | 9.30M | -61.09% |
| Dec 31, 2012 | 23.90M | -28.01% |
| Dec 30, 2011 | 33.20M | -63.79% |
| Dec 31, 2010 | 91.70M | 102.88% |
| Dec 31, 2009 | 45.20M | -12.23% |
| Dec 31, 2008 | 51.50M | -48.91% |
| Dec 31, 2007 | 100.80M | 69.41% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.75B |
| UnitedHealth Group | 478.58B |
| Johnson & Johnson | 374.39B |
| AbbVie | 362.98B |
| Novo Nordisk | 301.38B |
| Abbott Laboratories | 228.81B |
| AstraZeneca | 225.76B |
| Merck & Co. | 218.75B |